Liposomal Bupivacaine vs Peripheral Nerve Block

• Status: Terminated
• Trial end date: 2021-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gerard Cush
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

1. Patients 18 years of age or older

2. Patients undergoing elective primary ankle or hindfoot surgery (ankle arthrodesis, subtalar arthrodesis, triple arthrodesis, total ankle arthroplasty, peroneal tendon debridement/transfer, Cavus Reconstruction, Medial Displacement Calcaneal Osteotomy, Dwyer Osteotomy)

Exclusion Criteria:

1. Patients who are undergoing revision surgical procedure

2. Patients who have taken opioid pain medications in the past 3 months prior to surgical procedure

3. Patients who have allergies to any of the medications or components of medications investigated in the study

4. Patients currently incarcerated

5. Patients who cannot read and speak English